glenzocimab (ACT 017) - Acticor Biotech
http://www.ncbi.nlm.nih.gov/pubmed/40171679
 
Bernhard Nieswandt; David Stegner; Stefano Navarro
 
Apr 2, 2025
 
Prev Next